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They are responsible for the biochemical and morphological changes associated with apoptosis [4] . It has been proposed that caspases can be divided into two categories: "initiator" caspases with a long prodomain, such as caspase-9, and "effector" caspases such as caspase-3 [5] . Caspase-3 has been shown to be a key component involved in the underlying mechanisms of apoptosis [6] , and the activation of caspase-3 is considered to be the final step in many apoptotic pathways [7] . Most commonly, two major apoptotic pathways have been identified: the death receptor pathway [8] and the mitochondrial pathway [9] . Signal transduction and execution of apoptosis require the activation of the caspase cascade [10] . Most apoptosis depending on the caspase cascade, as well as the cascade the process itself, is obstructed by caspase-inhibitors [11] [12] [13] . The current method to monitor caspase activities includes the use of caspase substrates and inhibitors [14] [15] [16] [17] [18] [19] [20] [21] . Previously, we constructed tandem fused fluorescent proteins with two colors for measurement of caspase-3 activity [22] , and three colors for measurement of caspase-3 and caspase-9 activities [23] by using FCCS. In this study, we carried out FCCS analysis and found that caspase-9 was activated earlier than caspase-3 in apoptotic cells.
Moreover, the combination of FCCS and three colors tandem fused fluorescent proteins can predict progression of the cell to apoptosis before the morphologic changes appeared.
Materials and methods
Plasmids and chemicals. The CRY chimera encoded ECFP, DEVD, which is a caspase-3 recognition site, mCherry [24] , LEHD, which is a caspase-9 recognition site, and Venus [25] (Fig. 1A , ECFP-DEVD-mCherry -LEHD-Venus, CRY chimera). ECFP and mCherry pairs and mCherry and Venus pairs have been reported to be adequate for in vitro and in cell by FCCS measurements [23] . TNF-α (Med. & Biol. Lab) was dissolved in water and diluted into other adequate buffers. CHX (Med. & Biol. Lab), caspase-3 inhibitor II (Calbiochem), which consists of a z-DEVD-fmk inhibitor sequence and caspase-9 inhibitor I (Calbiochem), which consists of a z-LEHD-fmk inhibitor sequence were dissolved in DMSO, and diluted to final concentrations containing less than 0.1% DMSO using Dulbecco's modified Eagle's medium (DMEM, Sigma). Induction and inhibition of apoptosis. For induction of apoptosis, the CRY chimera-expressing HeLa cells were incubated with 250 ng/ml TNF-α and 20 μg/ml CHX in humidified air with 5% CO 2 at 37°C. To specifically inhibit caspase-3 or caspase-9, the CRY chimeraexpressing HeLa cells were treated with 5 μM caspase-3 inhibitor II or 25 μM caspase-9 inhibitor I two hours before addition of TNF-α/CHX. with an LSM510-ConfoCor3 (Carl Zeiss), the setup of which followed our previous report [23] . ECFP and Venus were excited at the 458 nm laser line because the brightness of Venus was sufficient in this case for FCCS measurement, and mCherry was excited at the 594 nm laser line. 
where 
and particles that have both red and cyan fluorescence (N cross(CR) ), or red and yellow fluorescence (N cross(RY) ) can be calculated. Here, the RCA Mix value reported previously was used for cell lysates [23] .
Results

TNF-α/CHX-induced time-dependent activation of caspases in HeLa cell lysates
In this study a fusion protein was constructed and named CRY chimera.
As shown in Fig. 1A , the CRY chimera was formed by inserting DEVD and LEHD amino acids between ECFP and mCherry and mCherry and Venus, respectively. The CRY chimera-expressing HeLa cells are shown in Fig.   1B . DEVD sequences between ECFP and mCherry and LEHD sequences between mCherry and Venus could be cleaved by the activated caspase-3 and caspase-9, respectively. The cross-correlation of CRY chimera was observed in fluorescent protein pairs ECFP and mCherry (C-DEVD-R) and mCherry and Venus (R-LEHD-Y) in HeLa cells (Fig. 1C and D) . To evaluate the activation of caspase-3 and caspase-9, FCCS measurements were carried out in HeLa cell lysates. The CRY chimera-expressing HeLa cells were incubated with TNF-α/CHX for 0 min, 30 min, and 60 min, then lysed with lysis buffer. To subtract the background of various cell contents, the normalized RCA was calculated. Before addition of TNF-α/CHX, the highest amplitude was defined as activity of 1.0 and used as the control for cleavage. A decrease of the normalized RCA of C-DEVD-R was not observed at 30 min, but a significant decrease of the normalized RCA of C-DEVD-R was observed at 60 min after TNF-α/CHX treatment ( Fig. 2A) .
On the other hand, significant decreases of the normalized RCA of R-LEHD-Y were already observed at 30 min and also 60 min after TNF-α/CHX treatment (Fig. 2B) . These results indicate that caspase-9 could be activated earlier than caspase-3 after TNF-α/CHX treatment. In apoptotic cell lysates, there might be caspase-3, caspase-9, and other protease activities induced by TNF-α/CHX. To confirm the specificity of caspase-3 for DEVD and caspase-9 for LEHD, inhibitor experiments were carried out. As shown in Fig. 2A , in the presence of caspase-3 inhibitor II (C3Inhi), the decreases of the normalized RCA of C-DEVD-R
were not observed at 30 min and 60 min after TNF-α/CHX treatment.
Interestingly, in the presence of caspase-9 inhibitor I (C9Inhi), only a small decrease of the normalized RCA of C-DEVD-R was observed at 60 min after TNF-α/CHX treatment ( Fig. 2A) . As shown in suggested that the cascade from caspase-9 to caspase-3 was blocked.
Time-course FCCS measurement for detection of caspase-3 activation in single living cells Next, we subjected the CRY chimera to time-course measurement using FCCS. HeLa cells expressing the CRY chimera were analyzed every 5 min after TNF-α/CHX treatment (Fig. 3) . For FCCS measurements, weakly fluorescent cells were selected to obtain sufficient auto-and crosscorrelation amplitudes. To reduce the background effect of the live cell, the normalized RCA was also calculated. The cross-correlation signals of C-DEVD-R were detected in HeLa cells at the indicated times after TNF-α/CHX treatment (Fig. 3A) . LSM images of C-DEVD-R were obtained at 0 min and 30 min after TNF-α/CHX treatment ( Fig. 3B and   3C ). Decreases of the normalized RCA of C-DEVD-R were observed in cells 1, 3, 4, and 5 ( Fig. 3A) , whereas apoptotic morphology was only observed in cells 4 and 5 at 30 min after TNF-α/CHX treatment (Fig. 3C) . To identify whether the cells in which the normalized RCA decreased became apoptotic, long-term time-course FCCS measurement for detection of caspase-3 activation was carried out in single living cells. A decrease of the normalized RCA of C-DEVD-R was observed (Fig. 3D) , but no change of cell morphology was observed in the first 90 min after TNF-α/CHX treatment (Fig. 3F) . The apoptotic morphology appeared at 180 min after TNF-α/CHX treatment, and a very low value of the normalized RCA was obtained. These results demonstrated that a decrease in the normalized RCA of C-DEVD-R showed the activation of caspase-3 and could predict progression of the cell to apoptosis before the morphologic changes appeared.
Time-course FCCS measurement for detection of caspase-9 activation in single living cells Time-course FCCS measurement for detection of caspase-9 activation was also carried out in single living cells (Fig. 4) . The cross-correlation signals of R-LEHD-Y were detected in HeLa cells at the indicated times after TNF-α/CHX treatment (Fig. 4A) . LSM images of R-LEHD-Y were obtained at 0 min and 30 min after TNF-α/CHX treatment ( Fig. 4B-E) .
Decreases of the normalized RCA of R-LEHD-Y were observed but apoptotic morphology was not observed in cells 3 and 4 at 30 min after TNF-α/CHX treatment. Here, long-term time-course FCCS measurement for detection of caspase-9 activation was also carried out in single living cells.
Although no change of cell morphology was observed at 30 min after TNF-α/CHX treatment (Fig. 4H) , a decrease of the normalized RCA of R-LEHD-Y was observed (Fig. 4F) . A depressed value of the normalized RCA was observed when apoptotic cell morphology appeared at 240 min after TNF-α/CHX treatment (Fig. 4I) . Thus the decrease of the normalized RCA of R-LEHD-Y also could predict the progression of the cells to apoptosis before morphologic changes appeared. Moreover, the decrease of the normalized RCA of R-LEHD-Y started at least 15 min earlier than that of C-DEVD-R. These results suggested that caspase-9 was activated earlier than caspase-3 in apoptotic cells.
Discussion
In this study, we successfully confirmed that cross-correlation measurement could clearly distinguish the difference between chimeral and unlinked fluorescent proteins. In the bulk measurement, the decreases of the normalized RCA of R-LEHD-Y were observed (Fig. 2B ).
On the other hand, no decrease of the normalized RCA of C-DEVD-R was observed at 30 min after TNF-α/CHX treatment. The results indicated that caspase-9 was activated earlier than caspase-3.
In single living cell analysis for detection of caspase-3 and caspase-9 activation ( Fig. 3 and Fig. 4 
